Mini-monoka stenting for patients with perennial allergic conjunctivitis

Lior Or*, David Zadok, Morris E. Hartstein

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


Purpose: To assess the effectiveness of mini-monoka (MM) stenting in treating patients with perennial allergic conjunctivitis (PAC) and punctal stenosis. Methods: A retrospective case analysis was performed on 20 patients (40 eyes) who suffered from PAC with punctal stenosis who underwent MM (FCI Ophthalmics, Pembroke, MA, USA) stenting. Results: Nineteen patients (95%) were females, with an age range of 19–66 years (average 40.6 ± 25.4 years). All 20 patients (100% of eyes) had signs of PAC and punctal stenosis. All 20 patients (40 eyes) had received previous topical treatment including steroids. Nineteen patients (95% of eyes) had significant improvement in their allergy symptoms (tearing and conjunctival inflammation) following MM stenting. Conclusions: Stenosis of the punctum may play a role in the relapsing symptoms in PAC. MM stenting is a simple, safe, effective, and relatively non-invasive treatment option for the management of PAC in the presence of punctal stenosis.

Original languageEnglish
Pages (from-to)285-289
Number of pages5
Issue number4
StatePublished - 2019
Externally publishedYes


  • Mini-monoka stenting
  • allergic conjunctivitis
  • chronic allergic conjunctivitis
  • perennial allergic conjunctivitis
  • punctal stenosis


Dive into the research topics of 'Mini-monoka stenting for patients with perennial allergic conjunctivitis'. Together they form a unique fingerprint.

Cite this